购物车
全部删除
您的购物车当前为空
WZH-15-125 是一种高效的ALK抑制剂,能够有效克服耐药性,尤其针对复合ALK突变。对于Lorlatinib耐药的高度难治性G1202R/L1196M突变,其IC50为101.7 nM。WZH-15-125 可用作PROTAC靶蛋白配体,以合成PROTACWZH-17-002,并适用于非小细胞肺癌的研究。

WZH-15-125 是一种高效的ALK抑制剂,能够有效克服耐药性,尤其针对复合ALK突变。对于Lorlatinib耐药的高度难治性G1202R/L1196M突变,其IC50为101.7 nM。WZH-15-125 可用作PROTAC靶蛋白配体,以合成PROTACWZH-17-002,并适用于非小细胞肺癌的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
WZH-15-125 相关产品
| 产品描述 | WZH-15-125 is a potent ALK inhibitor capable of overcoming resistance, particularly with complex ALK mutations. It exhibits an IC50 of 101.7 nM against the highly recalcitrant Lorlatinib-resistant G1202R/L1196M mutation. Additionally, WZH-15-125 can serve as a PROTAC target protein ligand for synthesizing PROTACWZH-17-002. This compound is applicable in non-small cell lung cancer research. |
| 分子量 | 745.73 |
| 分子式 | C33H45BrN8O5S |
| CAS No. | 2845188-22-7 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容